Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer, Hematological”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00763490
What this trial is testing

Trial Of Double Umbilical Cord Blood Transplantation

Who this might be right for
Hematological Malignancies
University of Michigan Rogel Cancer Center 20
Not applicableLooking for participantsNCT07670949
What this trial is testing

Biodistribution, Dosimetry, and Safety of 68Ga-EV203 in Hematological Malignancies

Who this might be right for
Hematological Malignancies B
Zhejiang Cancer Hospital 30
Early research (Phase 1)Study completedNCT00472368
What this trial is testing

Determine the Absorption, Distribution, Metabolism, and Excretion of LBH589

Who this might be right for
Cancer Patients With Advanced Solid Tumors Including Lymphoma or Chronic Hematological Malignancies
Novartis Pharmaceuticals 4
Not applicableUnknownNCT03556748
What this trial is testing

WB-EMS and Nutrition in Patients With Hematological Malignancies

Who this might be right for
Hematologic DiseasesCachexia; CancerLeukemia+3 more
University of Erlangen-Nürnberg Medical School 40
Large-scale testing (Phase 3)Study completedNCT00893555
What this trial is testing

Pharmacologic Optimization of Voriconazole

Who this might be right for
Invasive Fungal InfectionHematological Malignancy
Jan-Willem C Alffenaar 189
Testing effectiveness (Phase 2)UnknownNCT01220544
What this trial is testing

Haploidentical Transplantation With Early Adoptive Transfer of CD56+CD3- NK Cells

Who this might be right for
Acute Myeloid LeukemiasAdvanced Hematological MalignanciesIndication for Allogeneic Stem Cell Transplantation+1 more
Charite University, Berlin, Germany 30
Not applicableStudy completedNCT02279121
What this trial is testing

ATAPAC Study (TauroLock Activity in Adult Cancer Patients)

Who this might be right for
Catheter-Related Infections
Centre Hospitalier Régional Metz-Thionville 162
Post-approval studies (Phase 4)Study completedNCT01198236
What this trial is testing

Efficacy of Itraconazole as Secondary Prophylaxis in Patients Undergoing Allogeneic Stem Cell Transplantation or Chemotherapy With Prior Invasive Fungal Infection

Who this might be right for
Invasive Fungal Infection
Zhejiang University 150
Early research (Phase 1)Study completedNCT01204164
What this trial is testing

Phase 1 Study of TG02 Citrate in Patients With Advanced Hematological Malignancies

Who this might be right for
AMLALLBlast Crisis+2 more
Tragara Pharmaceuticals, Inc. 120
Early research (Phase 1)Study completedNCT00890500
What this trial is testing

Safety and Efficacy of ProHema Modulated Umbilical Cord Blood Units in Subjects With Hematologic Malignancies.

Who this might be right for
Hematologic MalignanciesAllogeneic Stem Cell Transplantation
Fate Therapeutics 12
Testing effectiveness (Phase 2)Active Not RecruitingNCT03837899
What this trial is testing

Durvalumab and Tremelimumab for Pediatric Malignancies

Who this might be right for
Pediatric CancerSolid Tumor PediatricHematological Malignancies
AstraZeneca 50
Not applicableStudy completedNCT06230965
What this trial is testing

Clinical Study of Lung Protective Ventilation Strategies and Tumor Microenvironment

Who this might be right for
Tumor Microenvironment
Affiliated Hospital of Nantong University 60
Testing effectiveness (Phase 2)Study completedNCT00134017
What this trial is testing

Combination Chemotherapy, Bone Marrow Transplant, and Post Transplant Cyclophosphamide for Hematologic Cancer

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+2 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 142
Testing effectiveness (Phase 2)Study completedNCT01860170
What this trial is testing

Post-Transplant Bortezomib and High Dose Cyclophosphamide as Graft-Versus-Host Disease (GVHD) Prophylaxis

Who this might be right for
Hematological Malignancy
Corewell Health West 28
Not applicableLooking for participantsNCT07788729
What this trial is testing

Social Prescriptions and Micro-Learning to Improve Care for Cancer Patients and Their Support Persons

Who this might be right for
CancerLung CancerColorectal Cancer+2 more
University of Regensburg 384
Testing effectiveness (Phase 2)Study completedNCT00433745
What this trial is testing

Wilm's Tumor 1 (WT1) Peptide Vaccine for High Risk Hematologic Malignancy

Who this might be right for
Myelodysplastic SyndromeAcute Myeloid Leukemia (AML)Chronic Myeloid Leukemia (CML)
National Heart, Lung, and Blood Institute (NHLBI) 4
Early research (Phase 1)UnknownNCT04599556
What this trial is testing

Clinical Trial for the Safety and Efficacy of Anti-CD7 CAR-T Cell Therapy for Patients With Relapsed or Refractory CD7 Positive Hematological Malignancy

Who this might be right for
CD7+ Acute LeukemiaCD7+ Lymphoma
Zhejiang University 81
Early research (Phase 1)Study completedNCT04681105
What this trial is testing

Flotetuzumab for the Treatment of Relapsed or Refractory Advanced CD123-Positive Hematological Malignancies

Who this might be right for
Recurrent Acute LeukemiaRecurrent B Acute Lymphoblastic LeukemiaRecurrent Blastic Plasmacytoid Dendritic Cell Neoplasm+14 more
City of Hope Medical Center 13
Testing effectiveness (Phase 2)Ended earlyNCT04735575
What this trial is testing

A Ph1/2 Study of EMB-06 in Participants With Relapsed or Refractory Myeloma

Who this might be right for
Relapsed or Refractory Multiple Myeloma
Shanghai EpimAb Biotherapeutics Co., Ltd. 40
Testing effectiveness (Phase 2)Ended earlyNCT04083170
What this trial is testing

Cord Blood Transplant With Dilanubicel for the Treatment of HIV Positive Hematologic Cancers

Who this might be right for
Acute Erythroid LeukemiaAcute Lymphoblastic LeukemiaAcute Megakaryoblastic Leukemia+8 more
Fred Hutchinson Cancer Center 1
Next Page